Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 21, 2015 (11 years ago)

SUCRETS Sore Throat & Cough Vapor Cherry lozenges

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

SUCRETS Sore Throat & Cough Vapor Cherry lozenges, 18-count tin, Dist. By: Insight Pharmaceuticals, LLC, Trevose, PA 19053-8433

Recalling firm
Medtech Products, Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1113-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Medtech Products, Inc.

All 2015 recalls
Class II · Moderate risk

Clear Eyes Redness Relief Hand Pocket Pal Tray Display

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1835-2019
Class II · Moderate risk

Clear eyes REDNESS RELIEF

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Terminated cGMP deviation Medtech Products, Inc. D-1834-2019

Other labeling / mix-up recalls from 2015

All labeling / mix-up recalls
Class III · Low risk

NABUMETONE Tablets USP

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Terminated Labeling / mix-up Teva Pharmaceuticals USA D-0773-2016
Class II · Moderate risk

Rocuronium Bromide 50 MG/5ML INJ.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0222-57 D-0517-2016